Reduction of Plasma Immunoreactive Somatomedin C during Fasting in Humans*
David R. Clemmons(University of North Carolina at Chapel Hill), Judson J. Van Wyk, Janet W. McArthur(Massachusetts General Hospital), Inese Z. Beitins(Massachusetts General Hospital), Anne Klibanski(Massachusetts General Hospital), E. Chester Ridgway(Boston University), Louis E. Underwood(Massachusetts General Hospital)
Cited by 366
Related Papers
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Activation of p53 by MEG3 Non-coding RNA
|Journal of Biological Chemistry|2007|648